Target intelligence / Profile preview

Colonization factor antigen I fimbriae (CFA/I)

Target
CFA/I
Molecular classification
Fimbriae (bacterial adhesion pili), Adhesion protein complex, Class 5a fimbriae
01

Overview

CFA/I fimbriae are rigid, rod-like surface structures composed mainly of polymerized CfaB subunits and tip-located minor adhesive subunit CfaE[1][2][3][4][6]. They are assembled through the alternate chaperone pathway, with a gene cluster (cfaABCE) directing their production[6]. CFA/I mediates the initial binding of ETEC bacteria to glycosphingolipids and other receptors on the small intestine epithelium, facilitating colonization and subsequent delivery of bacterial toxins that cause watery diarrhea[1][3][6]. The tip protein, CfaE, contains the primary receptor-binding domain[2][4], while CfaB binds a range of glycosphingolipid moieties[3][6]. Antigenic variation in surface-exposed regions is a key bacterial strategy to evade immune recognition[1]. CFA/I is a principal target for vaccine development, as antibodies that recognize its subunits can block ETEC attachment and provide protective immunity[1][4][6].

Other names
CFA/IColonization factor antigen IClass 5 fimbriae (specifically subclass 5a)Cfa fimbriae
02

Mechanism of action

Neutralizing/anti-adhesion antibodies block fimbriae-mediated attachment to host cells. Potential vaccine antigens trigger protective immune responses that block colonization.

03

Biological functions

Intestinal epithelial adhesionMediates bacterial colonizationInitiates pathogenesis of diarrheal disease
04

Disease associations

Infection (diarrheal disease by ETEC)Traveler's diarrhea
05

Safety considerations

Antigenic variation among CFA/I subunits may allow immune evasion, complicating vaccine developmentAs a non-host molecule, specific targeting is less likely to cause direct toxicity but may require broad coverage due to subunit variability
06

Interacting drugs

Antibodies

1 more in the full profile.

07

Biomarkers

Presence of CFA/I fimbriae or particular anti-CFA/I antibodies can serve as biomarkers for infection or vaccine efficacy

Beyond the preview

Go deeper on Colonization factor antigen I fimbriae (CFA/I).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Colonization factor antigen I fimbriae (CFA/I).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call